世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
Non-Invasive Prenatal Testing (NIPT) Market - A Global and Regional Analysis: Focus on Method, Test, Platform, End User, Application, and Region - Analysis and Forecast, 2023-2033
Global Non-Invasive Prenatal Testing Market Overview The global NIPT market was valued at $3,350.4 million in 2023 and is expected to reach $12,870.9 million by 2033, registering a CAGR of 14.41... もっと見る
SummaryGlobal Non-Invasive Prenatal Testing Market OverviewThe global NIPT market was valued at $3,350.4 million in 2023 and is expected to reach $12,870.9 million by 2033, registering a CAGR of 14.41% during the forecast period 2023-2033. The global NIPT market is primarily driven by the increase in encouraging NIPT guidelines, payers reimbursing for screening procedures, continued technology innovation, commercial potential across geographies, and growing preferences for non-invasive testing methods. Market Lifecycle Stage The global NIPT market is characterized by intense competition, as established entities and emerging players compete for a share of the market. The anticipated growth and transformation of the market bring forth both challenges and opportunities, rendering it a dynamic landscape to observe in the upcoming years. Industry Impact The confluence of micro and macro trends such as increasing awareness for early chromosomal abnormality detection and prevention, rise in adoption of non-invasive methods, and consumerization of diagnostic tests are driving the market toward future growth. The industry is expected to witness technological leaps with offerings beyond chromosomal abnormalities moving from research to clinical testing, early pregnancy testing enabling faster intervention, and increased affordability due to technological advancements and wider insurance coverage. Increase in research and development to address the current limitations and unmet needs will further propel the market growth in future. The industry's advancements in NIPT research and development continually address population health trends, disease prevalence, and treatment outcomes. As a result, the NIPT market's impact extends beyond technological integration for diagnosis, making it an integral component of global health strategies and broader ecosystem. Market Segmentation: Segmentation 1: by Application • Trisomy Detection • Microdeletion Detection • Sex Chromosome Aneuploidy Detection • Others Trisomy Detection to Dominate the Global Non-Invasive Prenatal Testing Market (by Application) The trisomy detection segment dominated the global NIPT market (by application) in FY2022. The high specificity, efficiency, and safety of NIPT (over 99% for trisomy 21), increased accessibility, rising incidence of chromosomal abnormalities, and increasing maternal age are collectively driving the market growth. Segmentation 2: by End User • Hospitals • Diagnostic Laboratories • Others Hospitals to Dominate the Global Non-Invasive Prenatal Testing Market (by End User) Larger patient database due to existing maternity and prenatal care services, both public and private hospitals specialized medical staff, easier access to genetic counselors and other specialists for pre- and post-test consultations, and potential integrated workflow with diagnostic procedures like amniocentesis in case of positive NIPT results are driving the hospital segment growth. Segmentation 3: by Platform • NGS • PCR • Others NGS to Dominate the Global Non-Invasive Prenatal Testing Market (by Platform) The global NIPT market (by product) was dominated by the NGS segment in FY2022. NGS-based NIPT tests are more prevalent due to shift in its affordability, high throughput and accuracy, integration with other technologies enabling efficient data interpretation, and shorter turnaround times. Segmentation 4: by Method • cfDNA • FCMB cfDNA to Dominate the Global NIPT Market (by Method) The global NIPT market (by product) was dominated by the cfDNA segment in FY2022. cfDNA analysis is being explored for additional applications like determining fetal sex, identifying single-gene disorders, and even assessing fetal health and development driving the growth. Segmentation 5: by Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The NIPT market in the Asia-Pacific region is witnessing significant growth of 15.43% in the forecast period, marked by increasing number of market players, and shifting healthcare landscape. In 2022, Asia-Pacific accounted for a share of 19.50% of the global NIPT market. Demand – Drivers, Restraints, and Opportunities Market Drivers: High Incidence of Genetic Disorders: With the rising incidence of genetic diseases, early diagnostic intervention is a key factor leading to the growth of NIPT solutions worldwide. Market Restraints: Stringent Regulatory Guidelines and Ethical Hurdles: Numerous regulatory bodies worldwide express concerns that the widespread implementation of NIPT and the subsequent surge in prenatal testing adoption could lead to an increase in abortion rates. Market Opportunities: Leveraging the Opportunities Arising from the Growing Markets in Asia: The growing markets in Asia present a significant opportunity for the noninvasive prenatal testing (NIPT) sector, providing avenues for expansion and innovation. As healthcare awareness and infrastructure continue to improve across Asian countries, there is an increasing demand for advanced prenatal screening technologies. Leveraging these opportunities involves tailoring NIPT solutions to meet the diverse genetic profiles and cultural considerations in the region. How can this report add value to an organization? Workflow/Innovation Strategy: The NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others. Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume. Competitive Strategy: Key players in the global NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market. Methodology Key Considerations and Assumptions in Market Engineering and Validation • The base year considered for the calculation of the market size is 2022. The historical year analysis has been done from FY2020 to FY2021, and the market size has been calculated for FY2022 and projected for the period 2023-2033. • The geographical distribution of the market revenue is estimated to be the same as the company’s net revenue distribution. All the numbers are adjusted to two digits after decimals for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR is calculated from 2023 to 2033. • The market has been mapped based on different types of products available in the market and based on several indications. All the key manufacturing companies that have a significant number of offerings to the NIPT market have been considered and profiled in the report. • In the study, the primary respondent’s verification has been considered to finalize the estimated market for the NIPT market. • The latest annual reports of each market player have been taken into consideration for market revenue calculation. • Market strategies and developments of key players have been considered for the calculation of sub-segment split. • The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website or from the annual reports of the respective company if stated. Primary Research The key data points taken from the primary sources include: • Validation and triangulation of all the numbers and graphs • Validation of the report’s segmentation and key qualitative findings • Understanding of the numbers of the various markets for market type • Percentage split of individual markets for regional analysis Secondary Research Open Sources • Food and Drug Administration (FDA), PubMed, and National Center for Biotechnology Information (NCBI) • Annual reports, SEC filings, and investor presentations of the leading market players • Company websites and detailed study of their portfolio • Gold standard magazines, journals, whitepapers, press releases, and news articles • Databases The key data points taken from the secondary sources include: • Segmentations, split-ups, and percentage shares • Data for market value • Key industry trends of the top players in the market • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation • Quantitative data for mathematical and statistical calculations Key Market Players and Competition Synopsis NIPT refers to a method of examining fetal deoxyribonucleic acid (DNA) to determine the risk of genetic abnormalities in the developing fetus. The testing is usually done by taking a sample of blood from a pregnant woman and analyzing small fragments of DNA that are circulating in a pregnant woman’s blood. The test helps in the screening of chromosomal abnormalities, specifically the trisomies that cause Down’s, Edward’s, and Patau’s syndromes. The global non-invasive prenatal testing market is in growth phase and rapidly expanding, creating opportunities for emerging players embracing targeted analysis without PCR or sequencing methods to enable broader adoption and challenge large players position in the market such as Natera, Illumina, LabCorp, Roche Molecular Systems/BioReference Laboratories, and BGI Genomics. Some of the prominent companies in this market are: • Agilent Technologies, Inc. • F. Hoffmann-La Roche Ltd • PerkinElmer, Inc. • Quest Diagnostics Incorporated • Illumina, Inc. • Myriad Genetics, Inc. • BGI Genomics • CENTOGENE N.V. • Laboratory Corporation of America Holdings • MedGenome Inc. • Annoroad Gene Technology • Natera, Inc. • Yourgene Health • Eurofins Scientific SE • Next Biosciences Companies that are not a part of the aforementioned pool have been well-represented across different sections of the report (wherever applicable). Table of ContentsExecutive SummaryScope and Definition 1 Markets 1.1 Trends: Current and Future Impact Assessment 1.1.1 Increasing Strategic Partnerships and Alliances between Market Players 1.1.2 Expanding Applications in NIPT Products 1.2 Supply Chain Overview 1.3 Research and Development Review 1.3.1 Patent Filing Trend (by Country, Year) 1.4 Regulatory Landscape 1.4.1 Regulatory Scenario in the U.S. 1.4.2 Regulatory Scenario in Canada 1.4.3 Regulatory Scenario in the U.K. 1.4.4 Regulatory Scenario in Germany 1.4.5 Regulatory Scenario in France 1.4.6 Regulatory Scenario in Spain 1.4.7 Regulatory Scenario in Italy 1.4.8 Regulatory Scenario in the Netherlands 1.4.9 Regulatory Scenario in China 1.4.10 Regulatory Scenario in India 1.4.11 Regulatory Scenario in Australia 1.4.12 Regulatory Scenario in Japan 1.5 Reimbursement Scenario 1.6 Market Dynamics Overview 1.6.1 Market Drivers 1.6.1.1 High Incidence of Genetic Disorders 1.6.1.2 Rising Maternal Age 1.6.1.3 Increasing Number of Reimbursement Policies toward Genetic Coverage 1.6.1.4 Increased Emphasis on Early Detection and Prevention 1.6.2 Market Restraints 1.6.2.1 Stringent Regulatory Guidelines and Ethical Hurdles 1.6.2.2 Lack of Awareness Regarding NIPT 1.6.2.3 Limitations and Considerations in Non-Invasive Prenatal Testing 1.6.3 Market Opportunities 1.6.3.1 Leveraging the Opportunities Arising from the Growing Markets in Asia 1.6.3.2 Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT) 2 Application 2.1 Application Segmentation 2.2 Application Summary 2.2.1 Application Summary 2.2.2 End User Summary 2.3 Global Non-Invasive Prenatal Testing Market (by Application) 2.3.1 Trisomy Detection 2.3.2 Microdeletion Detection 2.3.3 Sex Chromosome Aneuploidy Detection 2.3.4 Others 2.4 Global Non-Invasive Prenatal Testing Market (by End User) 2.4.1 Hospital 2.4.2 Clinics 2.4.3 Diagnostic Labs 2.4.4 Others 3 Products 3.1 Product Segmentation 3.2 Product Summary 3.2.1 Test Summary 3.2.2 Platform Summary 3.2.3 Method Summary 3.3 Global Non-Invasive Prenatal Testing Market (by Test) 3.3.1 Panorama and Vistara 3.3.2 MaterniT GENOME, MaterniT21 PLUS, and informaSeq 3.3.3 Verifi and Verifi Plus Prenatal Tests 3.3.4 NIFTY Test and NIFTY-Test Oro 3.3.5 QNatal Advanced 3.3.6 PrenaTest, GenaSafe, and PrenatalSAFE 3.3.7 Bambini Test 3.3.8 IONA and Sage 3.3.9 Other Harmony Test 3.4 Global Non-Invasive Prenatal Testing Market (by Method) 3.4.1 cfDNA 3.4.2 FCMB 3.5 Global Non-Invasive Prenatal Testing Market (by Platform) 3.5.1 NGS 3.5.2 PCR 3.5.3 Others 4 Regions 4.1 Drivers and Restraints 4.2 Regional Summary 4.3 North America 4.3.1 Regional Overview 4.3.2 Driving Factors for Market Growth 4.3.3 Factors Challenging the Market 4.3.4 Application 4.3.5 Product 4.3.6 U.S. 4.3.7 Canada 4.4 Europe 4.4.1 Regional Overview 4.4.2 Driving Factors for Market Growth 4.4.3 Factors Challenging the Market 4.4.4 Application 4.4.5 Product 4.4.6 France 4.4.7 Germany 4.4.8 U.K. 4.4.9 Spain 4.4.10 Italy 4.4.11 Rest-of-Europe 4.5 Asia-Pacific 4.5.1 Regional Overview 4.5.2 Driving Factors for Market Growth 4.5.3 Factors Challenging the Market 4.5.4 Application 4.5.5 Product 4.5.6 China 4.5.7 India 4.5.8 Japan 4.5.9 Rest-of-Asia-Pacific 4.6 Latin America 4.6.1 Regional Overview 4.6.2 Driving Factors for Market Growth 4.6.3 Factors Challenging the Market 4.6.4 Application 4.6.5 Product 4.6.6 Brazil 4.6.7 Mexico 4.6.8 Rest-of-Latin America 4.7 Middle East and Africa 4.7.1 Regional Overview 4.7.2 Driving Factors for Market Growth 4.7.3 Factors Challenging the Market 4.7.4 Application 4.7.5 Product 4.7.6 U.A.E. 4.7.7 South Africa 4.7.8 Rest-of-Middle East and Africa 5 Markets - Competitive Benchmarking & Company Profiles 5.1 Next Frontiers 5.2 Competitive Landscape 5.2.1 Agilent Technologies, Inc. 5.2.1.1 Overview 5.2.1.2 Product Portfolio 5.2.1.3 Top Competitors 5.2.1.4 Key Personnel 5.2.1.5 Target Customers 5.2.1.6 Analyst View 5.2.2 F. Hoffmann-La Roche Ltd 5.2.2.1 Overview 5.2.2.2 Product Portfolio 5.2.2.3 Top Competitors 5.2.2.4 Target Customers 5.2.2.5 Key Personnel 5.2.2.6 Analyst View 5.2.3 PerkinElmer, Inc. 5.2.3.1 Overview 5.2.3.2 Product Portfolio 5.2.3.3 Top Competitors 5.2.3.4 Target Customers 5.2.3.5 Key Personnel 5.2.3.6 Analyst View 5.2.4 Quest Diagnostics Incorporated 5.2.4.1 Overview 5.2.4.2 Product Portfolio 5.2.4.3 Top Competitors 5.2.4.4 Target Customers 5.2.4.5 Key Personnel 5.2.4.6 Analyst View 5.2.5 Illumina, Inc. 5.2.5.1 Overview 5.2.5.2 Product Portfolio 5.2.5.3 Top Competitors 5.2.5.4 Target Customers 5.2.5.5 Key Personnel 5.2.5.6 Analyst View 5.2.6 Myriad Genetics, Inc. 5.2.6.1 Overview 5.2.6.2 Product Portfolio 5.2.6.3 Top Competitors 5.2.6.4 Target Customers 5.2.6.5 Key Personnel 5.2.6.6 Analyst View 5.2.7 BGI Genomics 5.2.7.1 Overview 5.2.7.2 Product Portfolio 5.2.7.3 Top Competitors 5.2.7.4 Target Customers 5.2.7.5 Key Personnel 5.2.7.6 Analyst View 5.2.8 CENTOGENE N.V. 5.2.8.1 Overview 5.2.8.2 Product Portfolio 5.2.8.3 Top Competitors 5.2.8.4 Target Customers 5.2.8.5 Key Personnel 5.2.8.6 Analyst View 5.2.9 Laboratory Corporation of America Holdings 5.2.9.1 Overview 5.2.9.2 Product Portfolio 5.2.9.3 Top Competitors 5.2.9.4 Target Customers 5.2.9.5 Key Personnel 5.2.9.6 Analyst View 5.2.10 MedGenome Inc. 5.2.10.1 Overview 5.2.10.2 Product Portfolio 5.2.10.3 Top Competitors 5.2.10.4 Target Customers 5.2.10.5 Key Personnel 5.2.10.6 Analyst View 5.2.11 Annoroad Gene Technology 5.2.11.1 Overview 5.2.11.2 Product Portfolio 5.2.11.3 Top Competitors 5.2.11.4 Target Customers 5.2.11.5 Key Personnel 5.2.11.6 Analyst View 5.2.1 Natera, Inc. 5.2.1.1 Overview 5.2.1.2 Product Portfolio 5.2.1.3 Top Competitors 5.2.1.4 Target Customers 5.2.1.5 Key Personnel 5.2.1.6 Analyst View 5.2.2 Yourgene Health 5.2.2.1 Overview 5.2.2.2 Product Portfolio 5.2.2.3 Top Competitors 5.2.2.4 Target Customers 5.2.2.5 Key Personnel 5.2.2.6 Analyst View 5.2.3 Eurofins Scientific SE 5.2.3.1 Overview 5.2.3.2 Product Portfolio 5.2.3.3 Top Competitors 5.2.3.4 Target Customers 5.2.3.5 Key Personnel 5.2.3.6 Analyst View 5.2.4 Next Biosciences 5.2.4.1 Overview 5.2.4.2 Product Portfolio 5.2.4.3 Top Competitors 5.2.4.4 Target Customers 5.2.4.5 Key Personnel 5.2.4.6 Analyst View 6 Research Methodology 6.1 Data Sources 6.1.1 Primary Data Sources 6.1.2 Secondary Data Sources 6.1.3 Data Triangulation 6.2 Market Estimation and Forecast List of Figures Figure 1: Global Non-Invasive Prenatal Testing Market (by Region), $Million, 2022, 2026, and 2033 Figure 2: Prevalence of Genetic Disorders in Early Pregnancy, U.S., 2022 Figure 3: Global Non-Invasive Prenatal Testing Market (by Application), $Million, 2022, 2026, and 2033 Figure 4: Global Non-Invasive Prenatal Testing Market (by End User), $Million, 2022, 2026, and 2033 Figure 5: Global Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022, 2026, and 2033 Figure 6: Global Non-Invasive Prenatal Testing Market (by Method), $Million, 2022, 2026, and 2033 Figure 7: Global Non-Invasive Prenatal Testing Market, Recent Developments, 2023 Figure 8: Supply Chain of Global NIPT Market Figure 9: Global NIPT Market, Patent Analysis, (by Country), January 2020-December 2023 Figure 10: Global NIPT Market, Patent Analysis, (by Year), January 2020-December 2023 Figure 11: Reimbursement Scenario in Major Countries of the Global NIPT Market Figure 12: Impact Analysis of Market Navigating Factors, 2022-2033 Figure 13: Births with Trisomies per 100,000 Live Births in Europe Region, 2000-2021 Figure 14: Age of Mother at Childbirth over the Years Figure 15: Reimbursement Scenario in Major Countries Figure 16: Number of Tests Processed by Natera, Inc., 2018-2020 Figure 17: Positives from Data of 75,000 NIPT Tests Showing False Positives Figure 18: Recent Developments in APAC by Key Companies Figure 19: North America Non-Invasive Prenatal Testing Market, Thousand Unit, 2023-2033 Figure 20: North America Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 21: U.S. Non-Invasive Prenatal Testing Market, Thousand Unit, 2023-2033 Figure 22: U.S. Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 23: Canada Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 24: Canada Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 25: Europe Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 26: Europe Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 27: France Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 28: France Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 29: Germany Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 30: Germany Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 31: U.K. Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 32: U.K. Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 33: Spain Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 34: Spain Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 35: Italy Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 36: Italy Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 37: Rest-of-Europe Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 38: Rest-of-Europe Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 39: Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 40: Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 41: China Non-Invasive Prenatal Testing Market, Thousand, 2023-2033 Figure 42: China Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 43: India Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 44: India Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 45: Japan Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033 Figure 46: Japan Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 47: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033 Figure 48: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 49: Latin America Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 50: Latin America Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 51: Brazil Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 52: Brazil Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 53: Mexico Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033 Figure 54: Mexico Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 55: Rest-of-Latin America Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033 Figure 56: Rest-of-Latin America Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 57: Middle East and Africa Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033 Figure 58: Middle East and Africa Non-Invasive Prenatal Testing Market, $Million, 2023-2033 Figure 59: U.A.E. Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033 Figure 60: U.A.E. Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 61: South Africa Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033 Figure 62: South Africa Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 63: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033 Figure 64: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market, $Million, 2022-2033 Figure 65: Share of Strategic Initiatives Figure 66: Data Triangulation Figure 67: Top-Down and Bottom-Up Figure 68: Assumptions and Limitations List of Tables Table 1: Market Snapshot Table 2: Global Non-Invasive Prenatal Testing Market, Opportunities Table 3: Market Share of Major Players Table 4: Key Companies’ Partnerships and Alliances Table 5: NIPT Tests in the NIPT Market and their Corresponding Applications Table 6: Risk of Chromosomal Abnormality w.r.t Maternal Age Table 7: Global Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 8: Global Non-Invasive Prenatal Testing Market (by Application), Thousand Units, 2022-2033 Table 9: Global Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 10: Global Non-Invasive Prenatal Testing Market (by End User), Thousand Units, 2022-2033 Table 11: Global Non-Invasive Prenatal Testing Market, by Test, $Million Table 12: Global Non-Invasive Prenatal Testing Market, by Platform, $Million Table 13: Global Non-Invasive Prenatal Testing Market, by Platform, Thousand Unit Table 14: Global Non-Invasive Prenatal Testing Market, by Method, $Million Table 15: Global Non-Invasive Prenatal Testing Market, by Method, Thousand Unit Table 16: Global Non-Invasive Prenatal Testing Market (by Region), Thousands Units, 2022-2033 Table 17: Global Non-Invasive Prenatal Testing Market (by Region), $Million, 2022-2033 Table 18: North America Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 19: North America Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 20: North America Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 21: North America Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 22: U.S. Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 23: U.S. Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 24: U.S. Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 25: U.S. Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 26: Canada Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 27: Canada Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 28: Canada Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 29: Canada Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 30: Europe Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 31: Europe Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 32: Europe Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 33: Europe Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 34: France Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 35: France Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 36: France Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 37: France Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 38: Germany Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 39: Germany Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 40: Germany Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 41: Germany Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 42: U.K. Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 43: U.K. Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 44: U.K. Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 45: U.K. Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 46: Spain Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 47: Spain Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 48: Spain Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 49: Spain Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 50: Italy Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 51: Italy Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 52: Italy Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 53: Italy Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 54: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 55: Rest-of-Europe Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 56: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 57: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 58: Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 59: Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 60: Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 61: Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 62: China Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 63: China Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 64: China Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 65: China Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 66: India Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 67: India Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 68: India Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 69: India Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 70: Japan Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 71: Japan Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 72: Japan Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 73: Japan Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 74: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 75: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 76: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 77: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 78: Latin America Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 79: Latin America Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 80: Latin America Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 81: Latin America Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 82: Brazil Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 83: Brazil Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 84: Brazil Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 85: Brazil Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 86: Mexico Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 87: Mexico Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 88: Mexico Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 89: Mexico Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 90: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 91: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 92: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 93: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 94: Middle East and Africa Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 95: Middle East and Africa Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 96: Middle East and Africa Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 97: Middle East and Africa Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 98: U.A.E. Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 99: U.A.E. Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 100: U.A.E. Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 101: U.A.E. Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 102: South Africa Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 103: South Africa Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 104: South Africa Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 105: South Africa Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 106: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033 Table 107: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033 Table 108: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033 Table 109: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033 Table 110: Market Share (2022) Press Release
The global non-invasive prenatal testing market is estimated to reach $12.87 billion by 2033, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 14.41% during the forecast period 2023-2033.
Non-invasive prenatal testing (NIPT) is a rapidly developing technology that is incessantly extending its scope in reproductive medicine. The global NIPT market is primarily driven by the increase in encouraging NIPT guidelines, payers reimbursing for screening procedures, continued technology innovation, commercial potential across geographies, and growing preferences for non-invasive testing methods. Additionally, the success of existing products, reduced test costs, and the launch of new innovative product lines and services have further propelled market growth. USP of the Report • Market Growth Potential • Patent Analysis • Regulatory Framework • Market Dynamics • Market Opportunities • Detailed Segmentation such as Application, End User, and Product • Region and Country-Level Market Size and Forecast for Application, End User, Test, Method, and Platform • Competitive Landscape Analyst Perspective According to Swati Sood, Principal Analyst at BIS Research, “The global NIPT market is experiencing growth driven by a confluence of factors. One of the primary drivers is the increasing prevalence of genetic disorders. Moreover, the market is driven by a growing number of government initiatives and increasing maternal age. Furthermore, growing healthcare landscape in Asia-Pacific act as an opportunity for the market players to strategically partner and further expand their business.” Key Companies Profiled Key players in the global NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market. The key players profiled in the report include Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, PerkinElmer, Inc., Quest Diagnostics Incorporated, Illumina, Inc., Myriad Genetics, Inc., BGI Genomics, CENTOGENE N.V., Laboratory Corporation of America Holdings, MedGenome Inc., Annoroad Gene Technology, Natera, Inc., Yourgene Health, Eurofins Scientific SE, and Next Biosciences Key Questions Answered in the Report • What is the importance of NIPT, and what are the different NIPT products/services available in the market? What are the different methods of NIPT, and what are the benefits and risks associated with them? • What are the major technological advancements witnessed by the global non-invasive prenatal testing market in the past four years, and what is the future scope of the market? What are the key trends of the global NIPT market, and how is the market evolving currently? • What was the market size of the global NIPT market in 2022, and what is the market size anticipated to be in 2033? What is the expected growth rate of the global NIPT market during the period 2022-2033? • What is the market scenario and growth potential of different regions of the world, including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa? • What are the major drivers, challenges, and opportunities within the global NIPT market? • Who are the major key players in the global NIPT market? How much market share did each of these players occupy in the market in 2022? Which companies are anticipated to be highly disruptive in the future, and why? • What is the regulatory scenario of the global NIPT market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of NIPT products? • What is the reimbursement scenario of the global NIPT market, and what is the reimbursement rate in different countries of the world, including countries of North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa? • What are the key developmental strategies implemented by the key players of the global NIPT market to sustain market competition? • What are the different NIPT services available in the market, and which test type dominated the market in 2022 and is expected to dominate 2033 in terms of value and volume? • What is the global market size (by value and volume) for different types of products in the global NIPT market in 2022? What are the key trends of the market with respect to different kits and assays, and which product is expected to dominate the market in 2033? • What are the different platforms supported by NIPT products? Which technology type dominated the market in 2023 and is expected to dominate in 2033 (by value and volume)? • What are the different applications associated with NIPT? What was the contribution of each of the application areas in the global NIPT market for the period between 2022 and 2033 (by value and volume)? • What is the global NIPT market size (by value and volume) based on different methods? Which method is currently leading the market and why? Which method is expected to lead the market during the forecast period? • Who are the different end users of the global NIPT market (by value and volume)? Which end-user type is the major contributor to revenue in the market? • Which region contributed the highest sales in the global NIPT market during 2022 and is expected to contribute the same in 2033? What are the leading countries of different regions that contribute significantly toward the growth of the NIPT market?
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
BIS Research社のヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（platform）の最新刊レポート
よくあるご質問BIS Research社はどのような調査会社ですか?多数のアナリストチームと大規模な業界専門家のネットワークを擁するBISリサーチは、市場に影響を与える革新的な技術に関して、高度なマーケットインテリジェンスを提供しています。特に、新興テクノロジーに関す... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |
